打开APP

以色列发明家打造网上医疗器械集资平台

  1. 以色列
  2. 医疗器械开发
  3. 网上集资

来源:生物谷 2013-08-23 09:55

2013年8月22日讯 /生物谷BIOON/ --当一种新型医疗器械处于开发阶段时,投资者会根据其预期的性能、安全性等数据来决定是否投资。这就给一些项目的起步带来很大困难。有鉴于此,来自以色列的Technion技术中心的Daniel Yachia试图通过建立一个名为B-a-MedFounde的网站来为刚刚起步的医疗器械开发项目提供平台向全世界的天使投资人展示其创意。

2013年8月22日讯 /生物谷BIOON/ --当一种新型医疗器械处于开发阶段时,投资者会根据其预期的性能、安全性等数据来决定是否投资。这就给一些项目的起步带来很大困难。有鉴于此,来自以色列的Technion技术中心的Daniel Yachia试图通过建立一个名为B-a-MedFounde的网站来为刚刚起步的医疗器械开发项目提供平台向全世界的天使投资人展示其创意。这种集资方式过去常见于集资电影等形式,而作为医疗器械研发集资的途径,还属首次。(生物谷Bioon.com)

详细英文报道:

While the venture capital route may work for device developers who have heaps of data on safety, effectiveness and market dynamics, those seeking seed cash to get rolling on a prototype often have a hard time making their way.

That's where B-a-MedFounder hopes to make a difference, opening a crowdfunding platform for early-stage inventors in angelic need.

Daniel Yachia, a professor of urology at Haifa's Technion-Israel Institute of Technology, co-founded the site to provide fledgling companies with a platform to tout their inventions and secure startup funds. At B-a-MedFounder.com, companies can list their innovative devices in a browsable database, and users of the site choose whether to donate--not invest--in projects.

"There are people in many different countries that have bright ideas, and they don't have the contacts in order to show them," Yachia told CNBC. "If you're not well-connected to big companies or funding yourselves, it's very difficult to get funding for your idea."

Crowdfunding has long been used to bankroll independent films, graphic novels and art projects, but it's a fairly new cash stream in the medical device industry. That said, the method has already bred success: Scanadu, an in-development diagnostic device modeled after Star Trek's Tricorder, set a record on crowdfunding platform Indiegogo when it raised about $1.7 million in just two months.

While websites like MedStartr, HealthFundr and Kickstarter allow medical device inventors to crowdsource their startup funds, B-a-MedFounder is focused specifically on companies that need less than $100,000 to get moving, Yachia said, filling a gap in the fundraising world that can halt early development

"If I have a project and I got to a VC, the minimum I need to ask for is $5 million, or they won't even look me in the face," he told CNBC.

Yachia is a veteran of the industry himself, holding more than 30 medical device patents since co-founding InStent, an Israeli company Medtronic ($MDT) bought for $200 million back in 1996.

 

版权声明 本网站所有注明“来源:生物谷”或“来源:bioon”的文字、图片和音视频资料,版权均属于生物谷网站所有。非经授权,任何媒体、网站或个人不得转载,否则将追究法律责任。取得书面授权转载时,须注明“来源:生物谷”。其它来源的文章系转载文章,本网所有转载文章系出于传递更多信息之目的,转载内容不代表本站立场。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。

87%用户都在用生物谷APP 随时阅读、评论、分享交流 请扫描二维码下载->